首页> 外文期刊>Thoracic cancer. >Survival and bronchial carcinoid tumors: Development of surgical techniques in a 30‐year experience of 82 patients in China
【24h】

Survival and bronchial carcinoid tumors: Development of surgical techniques in a 30‐year experience of 82 patients in China

机译:生存和支气管类癌:在中国82位患者的30年经验中发展外科技术

获取原文
获取外文期刊封面目录资料

摘要

AbstractBackground:  We aimed to identify the factors determining long-term survival after surgical management for bronchial typical carcinoid (TC) and atypical carcinoids (AC) and to compare the clinical outcome of the different surgical strategies used in the two periods of 1980–1994 and 1995–2005.Methods:  Records of 82 patients with an initial pathological diagnosis of bronchial carcinoid tumor who underwent surgical management from January 1980 to December 2009 were reviewed. Tumors were classified as TC or AC using the 2004 World Health Organization criteria.Results:  There were 60 TC and 22 AC. Surgical procedures included lobectomies, sleeve or bronchoplastic resections, pneumonectomies, wedge resections, and segmental resections. Significantly fewer pneumonectomies and more sleeve and bronchoplastic resections were performed after 1994. The prognosis was more favorable for TC than AC. Comparing lymph node status N0 with N1 + N2, 5- and 10-year survival was 92% and 85% vs. 61% and 41%. No patient with lymph node involvement survived more than 15 years.Conclusions:  Tumor subtype and lymph node status have the greatest impact on long-term survival following surgery. AC and/or regional lymph node metastases have the worst prognosis. Formal anatomic and tissue-saving lung resection plus systematic radical mediastinal lymphadenectomy for TC and AC should be standard.
机译:摘要背景:我们旨在找出决定支气管典型类癌(TC)和非典型类癌(AC)手术治疗后长期生存的因素,并比较1980-1994年和2004年这两个时期所采用的不同手术策略的临床结果。 1995-2005年。方法:reviewed回顾了1980年1月至2009年12月接受手术治疗的82例经初步病理诊断为支气管类癌的患者的记录。根据2004年世界卫生组织的标准,将肿瘤分为TC或AC。结果:有60 TC和22 AC。外科手术包括肺叶切除,套管或支气管增生切除,肺切除,楔形切除和节段性切除。 1994年后进行的肺切除术明显减少,而套管和支气管增生切除术则更多。TC的预后优于AC。将淋巴结状态N0与N1 + N2进行比较,5年和10年生存率分别为92%和85%,而61%和41%。没有淋巴结受累患者存活超过15年。结论:肿瘤亚型和淋巴结状况对手术后的长期生存影响最大。 AC和/或区域淋巴结转移的预后最差。常规解剖和节省组织的肺切除术以及针对TC和AC的系统性纵隔纵隔淋巴结清扫术应成为标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号